Katy Beckermann(@katy_beckermann) 's Twitter Profileg
Katy Beckermann

@katy_beckermann

Medical oncologist, focus on kidney cancer, drug development, and the immune system, wife, mother, runner, animal lover

ID:1089722553357295616

calendar_today28-01-2019 03:11:17

213 Tweets

950 Followers

756 Following

Follow People
π‚π‘πšπ§ππ₯𝐞𝐫 𝐏𝐚𝐫𝐀 πŒπƒ 𝐅𝐀𝐂𝐏(@CParkMD) 's Twitter Profile Photo

⭐️THRILLED to host this meeting w/ my good friend Dr. Cathy Eng in beautiful Nashville. Join us as we have the LEADING thought leaders discuss the latest data including a special appearance by the Oncology Brothers
Register hereπŸ‘‡
web.cvent.com/event/c61fd6dd…

Dr. Cathy Eng David R. Spigel, MD

⭐️THRILLED to host this meeting w/ my good friend Dr. Cathy Eng in beautiful Nashville. Join us as we have the LEADING thought leaders discuss the latest data including a special appearance by the @OncBrothers Register hereπŸ‘‡ web.cvent.com/event/c61fd6dd… @CathyEngMD @DavidRSpigel
account_circle
Katy Beckermann(@katy_beckermann) 's Twitter Profile Photo

Additional evidence that tumor genetics can reprogram tumor microenvironment. Great work by Melissa M Wolf thrilled to be part of this team, don’t forget the macrophages!

account_circle
Georges Gebrael(@ggebraelmd) 's Twitter Profile Photo

Just in ACS Journal Cancer πŸ‘‰Pts w/ clear cell mRCC from real world Flatiron database s/p ICI RxπŸ‘‰ Similar survival w/ cabo + ICI vs. cabo monoRx aligning w/ trial results UroToday.com OncoAlert @huntsmangu Umang Swami Neeraj Agarwal, MD, FASCO πŸ‘‡tinyurl.com/2w79fbt8

Just in @JournalCancer πŸ‘‰Pts w/ clear cell mRCC #kidneycancer from real world Flatiron database s/p ICI RxπŸ‘‰ Similar survival w/ cabo + ICI vs. cabo monoRx aligning w/ #CONTACT03 trial results @urotoday @OncoAlert @huntsmangu @umangtalking @neerajaiims πŸ‘‡tinyurl.com/2w79fbt8
account_circle
Katy Beckermann(@katy_beckermann) 's Twitter Profile Photo

Exciting update from Dr. Mike Atkins on the novel checkpoint inhibitor LAG3 and its potential role in kidney cancer treatment. πŸŒŸπŸ‘©β€πŸ”¬ Stay tuned for the latest developments in immunotherapy!

account_circle
Katy Beckermann(@katy_beckermann) 's Twitter Profile Photo

Congrats KidneyCAN thanks for your advocacy and organization! Through this networking we strive to improve research leading to increased cure for

account_circle
GU Oncology Now(@GUOncologyNow) 's Twitter Profile Photo

🧠 Updates on for month:

πŸŽ₯ In a new video, Katy Beckermann of Vanderbilt-Ingram Cancer Center and Thomas Hutson, DO, PharmD, PhD FACP discuss the long-term benefits of for patients with patients with relapsed or refractory advanced .

πŸ“Ί Watch Now: buff.ly/3wHiApI

account_circle
World GU Conference(@GUconference) 's Twitter Profile Photo

Exciting update! Thrilled to announce that Dr. Katy Beckermann will be joining the faculty for ! Stay tuned for more announcements and mark your calendars: hubs.la/Q02pN0bM0

Exciting update! Thrilled to announce that Dr. @katy_beckermann will be joining the faculty for #WorldGU24! Stay tuned for more announcements and mark your calendars: hubs.la/Q02pN0bM0 #WorldGU24 #urology #CME #kidneycancer
account_circle
GU Oncology Now(@GUOncologyNow) 's Twitter Profile Photo

πŸ‘€ : updates for month:

πŸ“Ί In a new video, Katy Beckermann of Vanderbilt-Ingram Cancer Center and Thomas Hutson, DO, PharmD, PhD FACP discuss the long-term benefits of for patients with patients with relapsed or refractory advanced .

πŸŽ₯ Watch Now: buff.ly/3wHiApI

account_circle
Dr. Kimryn Rathmell(@NCIDirector) 's Twitter Profile Photo

Although women are much more broadly represented in the cancer research workplace today, there are still both overt + subtle challenges to a woman chasing her dream. We need to recognize and address these barriers when we find them.

Although women are much more broadly represented in the cancer research workplace today, there are still both overt + subtle challenges to a woman chasing her dream. We need to recognize and address these barriers when we find them. #WomenInScience #WomenInSTEM #WomenInMedicine
account_circle
UroToday.com(@urotoday) 's Twitter Profile Photo

Socioeconomic disparities drive alarming racial gaps in patient survival rates. nirm The Johns Hopkins Brady Urological Institute joins Ruchika Talwar Vanderbilt Health to discuss his work on socioeconomic determinants and racial disparities in on UroToday > bit.ly/3RQbYfw

Socioeconomic disparities drive alarming racial gaps in #KidneyCancer patient survival rates. @nirmishsingla @brady_urology joins @RuchikaTalwarMD @VUMChealth to discuss his work on socioeconomic determinants and racial disparities in #RCC on UroToday > bit.ly/3RQbYfw
account_circle
Kathryn Gallaway, MD(@KE_Gallaway) 's Twitter Profile Photo

Not all patients benefit from adjuvant therapy in RCC, so identifying factors to guide patient selection is key.

Arpita Desai shares MRD GATE RCC a prospective, multicenter trial aimed to evaluate MRD-guided treatment de-escalation classic.clinicaltrials.gov/ct2/show/NCT06…

Not all patients benefit from adjuvant therapy in RCC, so identifying factors to guide patient selection is key. @ADESAIONCMD shares MRD GATE RCC a prospective, multicenter trial aimed to evaluate MRD-guided treatment de-escalation classic.clinicaltrials.gov/ct2/show/NCT06… #DAVABroadmoorGU
account_circle
Katy Beckermann(@katy_beckermann) 's Twitter Profile Photo

πŸ‘¨β€βš•οΈ Dr. Hans Hammers outlines rationale for targeting PTPN2 in RCCβ€”anticipating dual impact on cancer cells and immunomodulation. Excitement builds for upcoming clinical trial results with RCC cohort and KCRC involvement! πŸš€πŸ”

πŸ‘¨β€βš•οΈ Dr. @HHammersMD outlines rationale for targeting PTPN2 in RCCβ€”anticipating dual impact on cancer cells and immunomodulation. Excitement builds for upcoming clinical trial results with RCC cohort and KCRC involvement! πŸš€πŸ” #RCCResearch #KCRC
account_circle
Katy Beckermann(@katy_beckermann) 's Twitter Profile Photo

🌟 Dr. Pavlos Msaouel passion for Renal Medullary Carcinoma is palpable! Eager for insights from his translational research. πŸ§¬πŸš€ @RMCAlliance @DavaOncology

🌟 Dr. @PavlosMsaouel passion for Renal Medullary Carcinoma is palpable! Eager for insights from his translational research. πŸ§¬πŸš€ @RMCAlliance @DavaOncology #RMCResearch #CancerAwareness
account_circle
Katy Beckermann(@katy_beckermann) 's Twitter Profile Photo

πŸ‘¨β€βš•οΈπŸ’‘ Dr. James Brugarolas teaches us we can learn from each patient. His FH-deficient RCC case study, spotlighting glycolysis dependence, reshapes our understanding. πŸ§¬πŸ”¬ @DavaOncology
Tian Zhang, MD, MHS

πŸ‘¨β€βš•οΈπŸ’‘ Dr. @JBrugarolas teaches us we can learn from each patient. His FH-deficient RCC case study, spotlighting glycolysis dependence, reshapes our understanding. πŸ§¬πŸ”¬ @DavaOncology @TiansterZhang
account_circle
Katy Beckermann(@katy_beckermann) 's Twitter Profile Photo

πŸ”¬ Exciting strides in bladder cancer research by Randy Sweis ! 🌟 His elegant work unveils the intricate interplay of FGFR and the immune system. πŸ§ πŸ‘¨β€πŸ”¬ A crucial step in understanding this complex terrain! πŸš€πŸ”

πŸ”¬ Exciting strides in bladder cancer research by @RandySweisMD ! 🌟 His elegant work unveils the intricate interplay of FGFR and the immune system. πŸ§ πŸ‘¨β€πŸ”¬ A crucial step in understanding this complex terrain! πŸš€πŸ” #BladderCancer #FGFR #ImmuneResponse
account_circle